Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

House to Vote Thursday on Amended Obamacare Repeal Bill

As a critical vote to repeal "Obamacare" looms Thursday, House Republican leaders worked furiously on Wednesday to garner enough votes to begin dismantling the landmark health care reform law. Pressure to pass the repeal bill came directly from President Donald Trump on Tuesday, who met privately with House Republicans to convince defiant party members...

Posted today in Medical

FDA OKs Parkinson's Add-On Drug, Xadago (Safinamide)

The U.S. Food and Drug Administration has approved a new drug for Parkinson's disease. Xadago (safinamide) pills were given the green light as an add-on treatment for people taking levodopa/carbidopa and experiencing "off" episodes. These are periods when medication effectiveness wanes, leading to a rise in symptoms such as tremor and difficulty walking. "Parkinson's...

Posted 2 days ago in New Drug Approvals

FDA Approves Juvéderm Vollure XC for Correction of Facial Wrinkles and Folds in Adults

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market Juvéderm Vollure™ XC, for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21.1 In the US pivotal clinical...

Posted yesterday in New Drug Approvals

FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease

The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes. An “off” episode is a time when a patient’s medications are not working well, causing an increase in Parkinson’s symptoms,...

Posted 3 days ago in Clinical Trials

Lilly Announces Phase 3 MONARCH 2 Breast Cancer Study Of Abemaciclib Met Primary Endpoint Of Progression-Free Survival

Eli Lilly and Company (NYSE: LLY) today announced that its MONARCH 2 trial of abemaciclib met the primary endpoint of progression-free survival (PFS). The Phase 3 study evaluated abemaciclib, a cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, in combination with fulvestrant in women with hormone-receptor-positive (HR+), human epidermal growth factor...

Posted today in Medical

Heart Drug Digoxin May Raise Death Risk for Some Patients: Study

The heart drug digoxin might raise the risk of death in people with a common heart rhythm disorder, and those patients should not take the drug, a new study suggests. Researchers analyzed data from nearly 18,000 atrial fibrillation patients in an international stroke prevention trial, including about 32 percent who were on digoxin at the start of the...

Posted today in Medical

Smoking Rates Drop After Global Tobacco Treaty

After 180 countries agreed to a global tobacco control treaty in 2005, there was a 2.5 percent decrease in smoking worldwide during the next decade, a new study shows. All of the participating countries agreed to the World Health Organization Framework Convention on Tobacco Control (FCTC). Signing countries committed to introducing policies such as...

Posted today in Medical

New Parkinson's Drug Xadago Approved

Xadago (safinamide) tablets have been approved by the U.S. Food and Drug Administration as an add-on drug to treat Parkinson's patients who take levodopa or carbidopa but have instances of increased symptoms anyway, a condition doctors call "off" episodes. An "off" episode, when Parkinson's medication doesn't seem to work well, may include symptoms...

Posted today in Medical

Drug No Better Than Placebo for Lower Back, Leg Pain

The widely prescribed pain drug pregabalin (brand name: Lyrica) may be no better than a placebo when it comes to treating the back and leg pain known as sciatica, a new clinical trial suggests. The study, published March 22 in the New England Journal of Medicine, found that sciatica patients improved to the same degree whether they were given pregabalin...

Posted today in Medical

Foods Labeled 'Healthy' May Hide Unhealthy Secrets

Food products that claim to be no-fat, no-sugar, low-fat or reduced-salt aren't necessarily healthier, researchers say. The study authors looked at more than 80 million food and beverage purchases from 2008 to 2012. The purchases were made by more than 40,0000 U.S. households. The researchers found that 13 percent of food and 35 percent of beverage...

Read more news...

Recently added consumer and prescribing information: Xadago, Kisqali, Siliq, Qtern, Trulance, Rhofade, Rubraca, Eucrisa, Soliqua, Xultophy

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]

Posted in Blog

Off-Label or Off-Limits? Should You Use A Drug For An Unapproved Use?

Off-Label Drug Use: What Is It? You may be surprised to learn that you have probably been prescribed a medication “off-label” at one point or another by your doctor. Maybe you’ve heard of “off-label” drug use in the news, but what does this really mean? “Off-label” use of a drug refers to prescribing a medication […]

See more blog posts or follow us on twitter.

Hide